Infections

LATEST NEWS

High Prevalence of Antibiotic Use in First Nations Communities

By

Bradley van Paridon

A high prevalence of antibiotic use and skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus were identified in Indigenous Canadian communities.

S. aureus Colonization Increased in Skin Lesions in Lupus Patients

Patients with SLE have increased colonization with Staphylococcus aureus in cutaneous lupus erythematosus lesions.

Acyclovir Not Beneficial With HSV Oropharyngeal Reactivation

By

Zahra Masoud

Preemptive use of acyclovir does not seem to reduce the duration of mechanical ventilation in critically ill patients with herpes simplex virus (HSV) oropharyngeal reactivation.

Postoperative Infection With Risk for Long-Term Infection and Mortality

By

Bradley van Paridon

Data published in JAMA Surgery showed that patients with 30-day postoperative infection had a 3.2-fold higher risk for 1-year infection and a 1.9-fold higher risk for mortality compared with those with no infections.

Varicella Strain Identity in First and Second Herpes Zoster Infection Episodes

By

Bradley van Paridon

Varicella zoster virus (VZV) is extremely stable during the varicella replication phase and subsequent establishment of latency in sensory ganglia throughout the body.

Household Environment Plays Role in MRSA Acquisition

Frequent handwashing may reduce likelihood of novel strain introduction into the household

Social Risk Factors Associated With Post-Colectomy Surgical Site Infections

By

Zahra Masoud

Infection prevention programs targeting low-income groups undergoing colectomy may be important in reducing surgical site infections.

Antimicrobial Resistance Patterns Examined for Adult, Pediatric HAIs

The researchers found that the three most frequently reported pathogens were Escherichia coli, Staphylococcus aureus, and Klebsiella spp.

Risk for Skin Infections May Be Increased With Statin Use

Using statins for as short a time as three months can put patients at risk for developing diabetes and skin and soft tissue infections.

Update on Efficacy of Treatments for Cutaneous Candidiasis

By

Linda Peckel

A review finds that fluconazole is the only commercially available evidence-based option for systemic treatment of cutaneous candidiasis.